Found: 7
Select item for more details and to access through your institution.
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304324
- By:
- Publication type:
- Article
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111).
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1428, doi. 10.1002/ijc.33296
- By:
- Publication type:
- Article
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3149, doi. 10.3390/cancers12113149
- By:
- Publication type:
- Article
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis.
- Published in:
- BMC Gastroenterology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-230X-13-11
- By:
- Publication type:
- Article
Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis.
- Published in:
- 2013
- By:
- Publication type:
- journal article